ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects

Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

Teun van Gelder, J Klupp, M.J. Barten et al. · Therapeutic Drug Monitoring · 2001 · 333 citations

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Eric Nisbet‐Brown, Nancy F. Olivieri, Patricia J. Giardina et al. · The Lancet · 2003 · 330 citations

Iron-loaded Patients, Iron Metabolism, Hematology +5

Hepatocellular carcinoma in the thalassaemia syndromes

Caterina Borgna‐Pignatti, Gianluca Vergine, T. Lombardo et al. · British Journal of Haematology · 2003 · 175 citations

Pathology, Cirrhosis, Hepatobiliary Tumor +17

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.

Renzo Galanello, Antonio Piga, Daniele Alberti et al. · PubMed · 2003 · 171 citations

Pharmacotherapy, Iron Deficiency, Transfusion-dependent Iron Overload +16

VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz et al. · Drug Metabolism and Disposition · 2005 · 156 citations